PIK3CA c.2033_2034delinsTG ;(p.K678M)

Variant ID: 3-178938791-AA-TG

NM_006218.2(PIK3CA):c.2033_2034delinsTG;(p.K678M)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective.

Signal Transduction And Targeted Therapy
Yang, Yang Y; Li, Shuo S; Wang, Yujiao Y; Zhao, Yi Y; Li, Qiu Q
Publication Date: 2022-09-17

Variant appearance in text: PI3K: K678M
PubMed Link: 36115852
Variant Present in the following documents:
  • Main text
  • 41392_2022_Article_1168.pdf
View BVdb publication page



FGFR-TKI resistance in cancer: current status and perspectives.

Journal Of Hematology & Oncology
Yue, Sitong S; Li, Yukun Y; Chen, Xiaojuan X; Wang, Juan J; Li, Meixiang M; Chen, Yongheng Y; Wu, Daichao D
Publication Date: 2021-02-10

Variant appearance in text: PI3K: K678M
PubMed Link: 33568192
Variant Present in the following documents:
  • Main text
  • 13045_2021_Article_1040.pdf
View BVdb publication page



FGF/FGFR signaling pathway involved resistance in various cancer types.

Journal Of Cancer
Zhou, Yangyang Y; Wu, Chengyu C; Lu, Guangrong G; Hu, Zijing Z; Chen, Qiuxiang Q; Du, Xiaojing X
Publication Date: 2020

Variant appearance in text: PI3K: K678M
PubMed Link: 32127928
Variant Present in the following documents:
  • Main text
  • jcav11p2000.pdf
View BVdb publication page